0 likes | 16 Views
Trastuzumab Deruxtecan, also known as T-DXd, represents a paradigm shift in the treatment of HER2-positive breast cancer. With its unique mechanism of action, Trastuzumab Deruxtecan Injection delivers a potent payload directly to cancer cells, effectively halting their growth and proliferation. This targeted approach not only enhances efficacy but also minimizes the risk of adverse effects on healthy tissues, thereby improving patient outcomes and quality of life.<br>
E N D